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Abstract 
Vernonia amygdalina is a shrub or small tree which is widely used traditional medicinal plant for the treatment of 
schistomiasis, amoebic dysentery, malaria, veneral diseases, wounds, hepatitis and diabetes and gastrointestinal 
problems. The objective of this study was to extract, isolate and determine the structure of the constituents of 
biologically active crude extracts of the leaves of Vernonia amygdalina and its toxicity investigation on albino 
mice. Extraction was carried out by maceration; isolation and characterization were carried out by using 
chromatographic and spectroscopic technique respectively. The screening of secondary metabolites showed the 
presence of alkaloid, flavonoids, phenols, saponin, steroids and glycosides in methanol extract. Fractionation of 
crude extract was carried by using column chromatography. The isolation result afforded sesquiterpene which was 
elucidated by using spectroscopic methods (IR, 1H NMR, 13 C NMR and DEPT 135).  The acetone extract showed 
toxicity at higher dosage with LD50=824.6 mg/Kg but methanol extract did not show any toxicity up to 2000 mg/Kg 
to the albino mice. Due to high applicability of the plant a number of isolated compounds and chronic toxicity 
should be carried out for further information.  
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INTRODUCTION 
The World Health Organization stated that about 80% of the people in developing countries still rely on traditional 
plant derived medicines, mainly due to their lower price.  Medicinal plants represent a rich source of secondary 
metabolites. Due to their secondary metabolites plants are used medicinally in different countries and are a source 
of many potent and powerful drugs (Srivastava et al., 1996). A wide range of medicinal plant parts is used for 
extract as raw drugs and they possess varied medicinal properties. The different parts used include root, stem, 
flower, fruit, twigs exudates and modified plant organs. While some of these raw drugs are collected in smaller 
quantities by the local communities and folk healers for local used, many other raw drugs are collected in larger 
quantities and traded in the market as the raw material for many herbal industries (Uniyal et al., 2006).  
Plants have been a valuable source of natural products for maintaining human health, especially in the 
last decade, with more intensive studies for natural therapies (Nascimento et al., 2000). The herbal products today 
symbolize safety in contrast to the synthetics that are regarded as unsafe to human and the environment (Joy et al., 
2001). The characteristics of the plants that inhibit microorganisms are important for human health which have 
been researched in laboratories since 1926 (Ates and Erdogrul, 2003; Mythili and Ravindhran, 2012).  
Medicinal plant extracts may contain many bioactive phytochemicals which present a potential source of 
natural antioxidants (Zakaria et al., 2006). Their ability to act as potential antioxidants has been extensively 
investigated (Nitta et al., 2002). Vernonia amygdalina, is traditionally used in the study area for the treatment of 
different ailments. The plant, with up to 20 cm long elliptical leaves and rough bark, is a member of the Asteraceae 
family that grows as a small shrub to a height of 2-5 m. It is reputed to have several health benefits. The organic 
fraction extracts of the plant was shown to possess antimicrobial and antiparasitic activities (Hladik et al., 2005; 
Akinpelu et al., 1999), antioxidant and cytoprotective (Iwalokun et al., 2006) activities. It is also effective against 
amoebic dysentery (Moundipa et al., 2000), gastrointestinal disorders (Akah et al., 1995) and has cytotoxic effects 
towards human carcinoma cells of the nasopharynx (Kupchan et al 1969). Its antioxidant activity has been 
attributed to the presence of flavonoids (Igile et al., 1994). 
Despite the successful story on the use of plants in the treatments of different ailments the general 
acceptability has been limited by lack of scientific data to support the indigenous knowledge (Saad et al., 2006). 
It is therefore appropriate to conduct scientific scrutiny on the selected herb in order to determine their effective 
doses and possible toxicities. Such measure could possibly lead to new findings to treat diseases in lieu of 
depending solely on drug developments which may be time-consuming aside from causing side effects to human 
health after prolonged treatments. Keeping in view the importance of medicinal plant, the objective of this study 
was to screen out different secondary metabolites of Vernonia amygdalina and investigate acute toxicity of the 
plant. 
 
2. Materials and Methods 
The leaves of vernonia amygdalina were collected on February 2013 from Wolaita Zone, SNNPRS which is 
located 380 Km from Addis Ababa the capital of Ethiopia. A Voucher specimen is identified at the National 
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Herbarium (Ethiopia), Department of Biology, Addis Ababa University, Faculty of Natural Sciences. 
1H, 13C, and DEPT spectra were recorded on a Bruker advance 400 MHZ spectrometer with trimethyl saline as 
internal standard. Infrared (IR) spectra were obtained on perkins-Elmer Bx Infrared spectrometer using KBr disc 
in the range 4000-400cm-1, at Addis Ababa University chemistry laboratory. 
TLC analysis was carried out on 0.2mm thickness TLC plates of Merck silica gel 60 F254 coated on aluminium 
plate. Compounds on TLC were detected using UV light: while column chromatography was carried using silicagel, 
60 (mesh). 
 
Coding system 
In the coding system used for compounds, V stands for the Genus name Vernonia, A stands for the species name 
Amygdalina, M stands for Methanol extract, the number behind VAM indicates the fraction number of 
fractionation in which it is obtained in the increasing polarity of the solvent system. 
 
Extraction and isolation 
Extraction of plant material 
500 gm powder of air-dried leaf of vernonia amygdalina was first soaked with n-hexane for 3 days. After filtration, 
the extract was concentrated under reduced pressure and temperature of 400C using rotary evaporator to recover 
the solvent and the concentrated marc exhaustively extracted with methanol after soaking for 72 hours at room 
temperature. The extract was concentrated in rota-vapor and afforded 16 gm yellow residue. The same step was 
applied for acetone extraction. 
 
Screening of secondary metabolites on methanol extract. 
The extract was tested for the presence of bioactive compounds by using standard methods (Sofowra , 1993; Trease 
et al.,1989 and Harborne, 1973) 
 
Isolation of crude extract 
When crude extract developed on TLC it showed different number of identifiable colored spots, which was 
subjected to column chromatography on silica gel from which 33 fractions were collected with increasing polarity 
of solvent system. The column elution started with 30 ml of pure diethyl ether, followed by increasing polarity of 
solvent system, diethyl ether, ethyl acetate, ethanol and methanol. 
From the fractions, first five fractions were colorless and showed no spot on TLC of different solvent 
system. The remaining fractions were colorful. Fr-17 obtained with a solvent system EtOAC: C2H5OH in the ratio 
(12:18), Fr-22 C2H5OH: CH3OH (27:3), Fr-26 C2H5OH: CH3OH (15:15), Fr-29 C2H5OH: CH3OH (6:24), Fr-31 
CH3OH (100%), Fr-32 (CH3OH: H2O) (9:1) were colored. From these fractions, Fr-17 was taken to spectroscopic 
analysis due to its amount and level of purity. 
 
Toxicity 
A total number of 90 mice were used for the experiment. The extract (soluble in water) was dissolved in distilled 
water and different concentrations (dosages) as shown in the table 2 and 3. All the mice (age 5 weeks, weighing 
24-30 g) were acclimatized for 7 days before the experiment started. The animals were fasted for three hours prior 
to oral administration of the extract. The last group in each batch received only distilled water (as control) and was 
provided with normal food after 30 minutes the experiment started. The acute toxicity of the extract of Vernonia 
amygdalina was carried out by oral administration of the above dosages by gavages. The food was provided to all 
mice after 30 minutes of oral administration of the extract. After administrating the extract each cage strictly 
observed whether there was any physiological, physical or any death for the first one hour continuously then at the 
interval of 2 hours for one day. Each batch was kept for further seven days to check any delayed effect (Keshebo 
et al., 2014). 
Table 1 Dosage of the methanol extract Vernonia amygdalina to the albino mice 
Batch  Number of mice per  Cage (5 mice)  Dosage  in mg/Kg Observation  
1 1 250 Experimental 
2 500 Experimental 
3 750 Experimental 
4 1000 Experimental 
5 distilled water Controlled  
2 1 1250 Experimental 
2 1500 Experimental 
3 1750 Experimental  
4 2000 Experimental  
5 distilled water Controlled  
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Table 2 Dosage of the acetone extract Vernonia amygdalina to the albino mice 
Batch  Number of mice per  Cage (5 mice)  Dosage  in mg/Kg Observation  
1 1 250 Experimental 
2 500 Experimental 
3 750 Experimental 
4 1000 Experimental 
5 distilled water Controlled  
2 1 850 Experimental 
2 800 Experimental 
3 distilled water Controlled  
 
3. Results and Discussion 
Acute Toxicity result  
No death or any physiological change was observed in table 1 this shows that methanol extract of Vernonia 
amygdalina safe to the albino mice up to 2000 mg/Kg  for 7 days. But acetone extract of Vernonia amygdalina  
showed  toxic effect to the albino mice at the dosage of 1000 mg/Kg  table 2 batch 1 cage 4, all of the mice didn`t 
feed  for the first 2 hours  and there physiological nature was different from the control and finally they were 
started dying 15 hours after administration of the extract. 
In table 2 batch 2 cage 1, for the first one hour all of the mice did not feed and some of them shivered; 
one died after three days, the remaining were normal for the next four days. But in cage two there was slight 
physiological difference for the first one hour and moving to second hour there was no difference from the control 
up to 7 days. From the toxicity result of acetone LD50= 824.6 mg/Kg. That means acetone extract of Vernonia 
amygdalina is toxic at higher dosage to the albino mice. 
Table 3: Results of preliminary Phytochemical screening of plant secondary metabolites  
Plants  Alkaloids Flavonoides Phenols Steroid Saponin Glycoside Terpene 
Vernonia 
Amygdalina  
+ + + + + + + 
+ = positive result (present - = negative result (absent) 
 Characterization of compound VAM-17 
The compound VAM-17 is a yellow crystalline solid obtained from methanol extract. From TLC plate it 
shows a yellow color, which is a characteristic of  terpenes. Its structure elucidation was determined using 
spectroscopic techniques. The pure compound has R.f value 0.71 using EtOAC: C2H5OH (9:1) as a solvent system. 
 
Spectral data 
Compound VAM-17 Yellowish solid, IR Vmax (KBr) cm-1,3410, 2926, ,1711,1273,1076,631. 
13CNMR14.14,14.30,20.55,22.70,24.89,25.52,25.61,27.23,29.19,29.27,29.70,31.93,127.10,127.        
75,128.21,128.31, 130.19,131.95 
 1H NMR (400 MHZ, CDCl3) δ in ppm, 0.9, 1.0, 1.3, 1.6, 2.1, 2.3, 2.8, 5.4. 
From the IR Vmax (KBr) Cm-1 spectrum showed absorption band peaks assigned to different functional group 
stretching. The absorption band at 3410cm-1 shows stretching of OH group. The absorption band peak at 2926 
shows C-H stretch. The absorption band at 1711 is for carbon-carbon double bond stretch. The peak at 1273 is for 
C-H bending. The absorption band at 1076 is for =C-H bending. The absorption band at 631 is for C-H bending. 
Therefore, IR spectrum indicates the presence of hydroxyl group and carbon-carbon double bond in the compound 
isolated. 
From 1H NMR (400MHZ: CDCl3) spectrum showed a multiplate  peak at δ 5.4 is for proton of CH group bonded 
with hydroxyl group and methine group . A singlet peak at δ 2.8 indicates the OH hydrogen. The peak at 2.3 
indicates hydrogen bonded with C=C. The multiplet peak at 2.1 indicates the CH group that is bonded with C-O 
bond. The triplet peak at 1.6 indicates hydrogen bonded with CH2=CH2. The triplet peak at 1.3 indicates the 
CH2=CH2 group. The multiplet peak at 1.0 indicates the CH2 group that is bonded with CH3 and CH2. The triplet 
peak at 0.9 indicates the CH3 group that is bonded with CH2.  
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Table 4:  1H NMR data of compound VAM-17 
δ ( ppm) Multiplicity Remark 
0.9 T  
1.0 M  
1.3 T  
1.6 T  
2.1 M  
2.3 S  
2.8 S  
5.4 M  
From 13C NMR spectrum of the compound showed well resolved resonance of 18 carbon atoms. The  peaks at δ 
14.14 ppm and 14.30 ppm are for  methyl group  and the  peaks at 
20.55,22.70,24.89,25.52,25.61,27.23,29.19,29.27,29.70, are for methylene groups. The peaks at δ 31.93, 127.10, 
127.75,128.21,128.31,130.19,131.95 are for  methine groups. Therefore the compound VAM-17 has a total of 18 
carbons.  
Table 5:  13C NMR data of compound VAM-17 
Carbon No 13C NMR data, δ ppm DEPT-135 spectra Type of carbon 
1 131.95 CH Methine 
2 127.10 CH Methine 
3 20.55 CH2 Methylene 
4 22.70 CH2 Methylene 
5 24.89 CH2 Methylene 
6 31.93 CH Methine 
7 27.23 CH2 Methylene 
8 128.31 CH Methine 
9 128.21 CH Methine 
10 29.19 CH2 Methylene 
11 25.61 CH2 Methylene 
12 25.52 CH2 Methylene 
13 14.30 CH3 Methyl 
14 29.27 CH2 Methylene 
15 127.75 CH Methine 
16 127.10 CH Methine 
17 29.70 CH2 Methylene 
18 14.14 CH3 Methyl 
From DEPT 135 spectrum showed 18 peaks corresponding to 18 carbons. Compound VAM-17 has two methyl 
groups at δ 14.14 and 14.30. There are nine methylene groups  at δ 
20.55,22.70,24.89,25.52,25.61,27.23,29.19,29.27,29.70, and seven methine groups at δ 31.93 
127.10,127.75,128.21,128.31,130.19,131.95. The number of carbon atom indicates that it is a sesquiterpene. Based 
on the above evidences the expected structure of the compound VAM-17 is shown below. 
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Fig. 1 The Proposed structure of VAM-17 
 
Conclusion 
In this work the leaves extract of vernonia amygdalina has been analyzed. The plant contains important secondary 
metabolites alkaloids, flavonoides, phenols, saponin and glycosides which might be the cause for its medicinal 
values. In addition to screening of different types of secondary metabolites, isolation and characterization of 
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sesquiterpene was done by using chromatographic and spectroscopic technique. Furthermore, the plant acetone 
extract is toxic to albino mice but methanol extract is safe to albino mice up to the dosage of 2000mg/Kg. The 
LD50 of toxicity for the plant is 824.6 mg/Kg.  Further work is recommended to isolate the active compound (s) 
due to high applicability of the plant. 
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